Eight-week-old Heath is a world first. He was conceived in a pioneering infertility treatment trial with a new drug called kisspeptin.
This naturally occurring hormone stimulates ovaries more gently and naturally. This helps women undergoing IVF treatment avoid health complications associated with hyperstimulated ovaries, such as blood clots and kidney failure.
More trials are needed before the drug enters routine use. But hopefully these dangerous although rare complications will become a thing of the past, and that can only be good news for couples hoping to conceive.